What is "exomedicine"

Exomedicine is the study and exploration of medical solutions in the zero gravity environment of space to promote benefits to human health on Earth. The purpose is to advance the field, study, and practice of medicine on Earth through research investigations conducted in the microgravity conditions of space which may provide advances in understanding that cannot be achieved on Earth. Although the Soviet Union launched the first space station, Salyut 1 in 1971, the United States designed and launched Skylab with the intent of advancing the field of science both in space and with regards to terrestrial applications. Beginning as a “memorandum of understanding” between NASA and ESA in 1973, the first major microgravity experiments in space were carried out by “Spacelab”. Gravity is a fundamental force on earth that influences all biological systems at a molecular level. When biomedical research is conducted in Space, in so-called microgravity environments, certain earthbound limitations disappear, new and different findings are made, and living organisms behave very differently.

The term Exomedicine was coined by Kris Kimel president of the Kentucky Science and Technology Corporation and president founder of Kentucky Space LLC and a founder of Space Tango.